COMPANY PROFILE

Enobia Pharma

Explore full profile

Montreal, CanadaFounded 1997Biotech & Life Sciences

Valuation $100–250M Last recorded · 2011

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Enobia Pharma

Enobia operates in the mental health and wellness sector, providing an extensive online therapy platform that specializes in Cognitive Behavioral Therapy (CBT). The company serves individuals seeking mental health support, including those dealing with conditions such as ADHD, hypophosphatasia, and Oppositional Defiant Disorder (ODD). Enobia's market includes both direct consumers and healthcare providers looking for effective, evidence-based therapeutic solutions. The business model is subscription-based, where clients pay for access to therapy sessions, personalized guidance from licensed therapists, and a variety of mental health resources. Revenue is generated through these subscriptions as well as potential partnerships with healthcare institutions. Enobia's unique selling proposition lies in its comprehensive, evidence-based CBT programs and the convenience of online access, making mental health support more accessible and affordable.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 1997
Headquarters: Montreal, Canada
Employees: 7
Open positions: None listed
Dealroom signal: 25.0/100
Industry: Health
Sub-industry: Pharmaceutical
Sector: Biotech & Life Sciences, Biotechnology, Patient Care, Disease, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2c
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITIONOther financing	Dec 2011	$0	—	Alexion Pharmaceuticals	—
LATE VCOther financing	Aug 2011	$40M	$160M	Undisclosed	—

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Enobia Pharma website traffic

Latest recorded traffic for Enobia Pharma is 290 monthly website visits. Enobia Pharma's team declined 12.5% over the past year.

Latest monthly visits290 1-year team growth-12.5%

Monthly website visitsNov 2018–Apr 2023

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
PTProQR TherapeuticsDevelops RNA therapies to potentially transform the lives of patients suffering from genetic rare diseases	Leiden, Netherlands	Operational	202	$60M	$177M
SLSlope.ioProvider of a healthcare software designed to offer an easy way to prevent inventory outages	San Francisco, United States	Operational
VBVibe BioBuilding a community to find and fund treatments for rare diseases	Boston, United States	Operational
ENENU NutritionAnd commercializes nutritional products	Philadelphia, United States	Operational
GBGossamer BioFocused on the discovery and development of novel and differentiated therapeutic products	San Diego, United States	Operational
PHPhilEnd-to-end prescription management and delivery service connecting patients with local pharmacies	San Francisco, United States	Operational
O4O4cpO4CP - Only For Children Pharmaceuticals - Innovating For Child Care	Paris, France	Operational
IMImprimisRxCompounded ophthalmic formulations for physicians and patients.	Carlsbad, United States	Operational